Cargando…

Vaccines against Genital Herpes: Where Are We?

Genital herpes is a venereal disease caused by herpes simplex virus (HSV). Although HSV symptoms can be reduced with antiviral drugs, there is no cure. Moreover, because HSV infected individuals are often unaware of their infection, it is highly likely that they will transmit HSV to their sexual par...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyeon Cheol, Lee, Heung Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566015/
https://www.ncbi.nlm.nih.gov/pubmed/32727077
http://dx.doi.org/10.3390/vaccines8030420
_version_ 1783596060753526784
author Kim, Hyeon Cheol
Lee, Heung Kyu
author_facet Kim, Hyeon Cheol
Lee, Heung Kyu
author_sort Kim, Hyeon Cheol
collection PubMed
description Genital herpes is a venereal disease caused by herpes simplex virus (HSV). Although HSV symptoms can be reduced with antiviral drugs, there is no cure. Moreover, because HSV infected individuals are often unaware of their infection, it is highly likely that they will transmit HSV to their sexual partner. Once infected, an individual has to live with HSV for their entire life, and HSV infection can lead to meningitis, encephalitis, and neonatal herpes as a result of vertical transmission. In addition, HSV infection increases the rates of human immunodeficiency virus (HIV) infection and transmission. Because of the high burden of genital herpes, HSV vaccines have been developed, but none have been very successful. In this review, we discuss the current status of genital herpes vaccine development.
format Online
Article
Text
id pubmed-7566015
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75660152020-10-26 Vaccines against Genital Herpes: Where Are We? Kim, Hyeon Cheol Lee, Heung Kyu Vaccines (Basel) Review Genital herpes is a venereal disease caused by herpes simplex virus (HSV). Although HSV symptoms can be reduced with antiviral drugs, there is no cure. Moreover, because HSV infected individuals are often unaware of their infection, it is highly likely that they will transmit HSV to their sexual partner. Once infected, an individual has to live with HSV for their entire life, and HSV infection can lead to meningitis, encephalitis, and neonatal herpes as a result of vertical transmission. In addition, HSV infection increases the rates of human immunodeficiency virus (HIV) infection and transmission. Because of the high burden of genital herpes, HSV vaccines have been developed, but none have been very successful. In this review, we discuss the current status of genital herpes vaccine development. MDPI 2020-07-27 /pmc/articles/PMC7566015/ /pubmed/32727077 http://dx.doi.org/10.3390/vaccines8030420 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kim, Hyeon Cheol
Lee, Heung Kyu
Vaccines against Genital Herpes: Where Are We?
title Vaccines against Genital Herpes: Where Are We?
title_full Vaccines against Genital Herpes: Where Are We?
title_fullStr Vaccines against Genital Herpes: Where Are We?
title_full_unstemmed Vaccines against Genital Herpes: Where Are We?
title_short Vaccines against Genital Herpes: Where Are We?
title_sort vaccines against genital herpes: where are we?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566015/
https://www.ncbi.nlm.nih.gov/pubmed/32727077
http://dx.doi.org/10.3390/vaccines8030420
work_keys_str_mv AT kimhyeoncheol vaccinesagainstgenitalherpeswherearewe
AT leeheungkyu vaccinesagainstgenitalherpeswherearewe